Thoracic Aortic Dissection Clinical Trial
Official title:
Feasibility and Safety of Thrombosomes® on Time to Hemostasis in Patients Undergoing Emergency Surgery for Thoracic Aortic Dissections - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial
The hypothesis is that administration of Thrombosomes® (TBX®) as hemostatic support when terminating the cardiopulmonary bypass (CPB) in patients undergoing emergency surgery for acute thoracic aortic dissection (aTAD) is safe and least as effective when compared to standard Platelet Concentrates (stPC).
The study is designed as an exploratory phase 2a, single-center randomized, controlled pilot investigator-initiated trial of administration of Thrombosomes® (TBX®) versus standard platelet concentrates (stPC) in 20 aTAD patients per arm. The patients will be enrolled in the study over a period of 15 months. TBX® is a novel, human platelet (thrombocyte) derived lyophilized (freeze dried) hemostatic blood product for treatment of bleeding due to thrombocytopenia, dysfunctional platelet disorders or platelet consumption. The patients will be randomized to administration of either TBX®, or stPC, as part of the Massive Transfusion Protocol (MTP) at the time of termination of the cardiopulmonary bypass (CPB) in addition to standard goal-directed hemostatic optimization based on results from thrombelastography (TEG). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06270537 -
Post-market Clinical Trial of the Dominus® Stent-Graft
|
||
| Completed |
NCT00597870 -
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
|
N/A | |
| Recruiting |
NCT05639400 -
Thoraflex Hybrid and Relay Extension Post-Approval Study
|
||
| Active, not recruiting |
NCT04267055 -
DISSECT-N Post Market Data Collection Registry
|
||
| Completed |
NCT05414318 -
CTAG Dissection/Trauma Post Marketing Surveillance Japan
|
||
| Active, not recruiting |
NCT05610462 -
Trial of Exercise in Aortic Dissection Survivors
|
N/A | |
| Recruiting |
NCT05309707 -
ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"
|
||
| Recruiting |
NCT06336213 -
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
|
N/A | |
| Enrolling by invitation |
NCT03767777 -
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY（PATENCY）
|
N/A | |
| Enrolling by invitation |
NCT05155956 -
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
|
||
| Recruiting |
NCT03440697 -
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
|